ABVC vs ABVX

ABVC Biopharma, Inc. vs Abivax SA — Valuation Comparison 2026

ABVC

Biotechnology
ABVC Biopharma, Inc.
Quality
4.9
out of 10
Value Trap
24
SAFE
Price
$1.41
Last close
Models
8/13
Active
VS

ABVX

Biotechnology
Abivax SA
Quality
4.4
out of 10
Value Trap
12
SAFE
Price
$132.63
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType ABVC Fair ValueABVC Upside ABVX Fair ValueABVX Upside
Bayesian DCF Intrinsic $0.31 -78.3% $16.87 -87.3%
Earnings Power Value Intrinsic $47.73 -58.3%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.08 -94.4% $5.60 -95.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ABVC vs ABVX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ABVC vs ABVX — Which Stock Is More Undervalued?

ABVC scores higher with a 4.9/10 quality rating vs ABVX's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ABVC Biopharma, Inc. (ABVC) and Abivax SA (ABVX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ABVC currently trades at $1.41 with a QOC of 4.9/10, while ABVX trades at $132.63 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).